pocketful logo light
pocketful logo light
Pfizer Ltd logo

Pfizer Ltd

NSE: PFIZER BSE: 500680

4687.60

(2.04%)

Mon, 25 May 2026, 10:49 am

Pfizer Share Price Live Chart

1 Day

(2.04%)

No Result Found

Summary

  • Market Cap

    21395.76

  • Net Profit

    767.60

  • P/B

    4.34

  • Sector P/E

    45.26

  • P/E

    23.86

  • EV/EBITDA

    14.33

  • Debt/Equity (Industry)

    0.08

  • Interest Cover (Industry)

    42.77

  • ROCE (Industry)

    23.88

  • RONW (Industry)

    19.04

  • ROE

    19.78

  • ROCE

    27.27

  • Debt/Equity

    0

  • EPS (TTM)

    165.83

  • Dividend Yield

    1.60

  • Book Value

    918.71

  • Interest Cover

    0

Analysis

all

thumbs up icon

Pros

  • Dividends per share have increased over the past 10 years.
  • Dividends paid are well covered by earnings (4.9x coverage).
  • Pfizer is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Pfizer is profitable, therefore cash runway is not a concern.
  • Pfizer is profitable, therefore cash runway is not a concern.
thumbs up icon

Cons

  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • Pfizer's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
  • Pfizer's dividend is below the markets top 25% of dividend payers in India (3.08%).
  • Pfizer is not covered by any analysts.
  • Pfizer's 1-year earnings growth is less than its 5-year average (18.6% vs 25.2%)

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters63.9263.9263.9263.9263.92
FII2.812.712.602.392.18
DII16.8917.0517.1017.2317.10
Public16.3716.3216.3716.4516.80
Government0.000.000.000.000.00

Read More

Technical Analysis

RSI

46.25

MACD

-24.81

50 DMA

4766.78

200 DMA

4981.47

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic5595.205198.204954.404801.204557.404404.204007.20
Fibonacci5198.205046.554952.854801.204649.554555.854404.20
Camarilla4819.784783.384746.994801.204674.214637.824601.43

Pivots Level: Classic

R3

+794

5595.20

R2

+397

5198.20

R1

+153.20

4954.40

4801.20
4801.20
Pivot Point
LTP: 4689.20

S1

-243.80

4557.40

S2

-397

4404.20

S3

-794

4007.20

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    4726.57

  • 20-EMA

    4748.92

  • 30-EMA

    4762.25

  • 50-EMA

    4783.40

  • 100-EMA

    4837.31

  • 200-EMA

    4904.49

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
12 May 2026agm
12 May 2026board-meetingsAccounts, Dividend
09 Feb 2026board-meetingsQuarterly Results, Nine Months Results
09 Jun 2025dividendSpecial Dividend - Rs. - 13009 Jul 2025
19 May 2025agm
19 May 2025dividend₹35.00 Dividend /Share09 Jul 2025
09 Aug 2024agm
21 Jul 2024dividendFinal Dividend - Rs. - 3521 Aug 2024
17 May 2024dividend₹35.00 Dividend /Share21 Aug 2024
27 Jul 2023agm

Read More

Peer Comparison

Pfizer Ltd logo

Pfizer Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Cipla Ltd logo

Cipla Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Read More

Pfizer Ltd About

Pfizer is engaged in manufacturing, marketing, distribution and trading of pharmaceutical products.

Industry

Pharmaceuticals - Multinational

Founded

1950

Headquarters

CEO

Pradip P Shah

Employees

Contact

Website icon

Website

http://www.pfizerindia.com

Email icon

Email

contactus.india@pfizer.com

Phone icon

Phone

91-22-66932000

Location icon

Location

The Capital 1802/1901 Plot-C70, G Bl Bandra Kurla Cpx Bandra-E, Mumbai, Maharashtra, 400051

Read More

Pfizer Ltd Company History

YearHistory
2017
  • Acquired AstraZeneca’s Neksium for INR 750 million.
2018
  • Entered ICMR partnership on Antimicrobial Resistance.
2021
  • Pfizer and BioNTech finalized agreement to supply 200 million COVID-19 vaccine doses to EU.
2022
  • Launched ‘Pfizer PAP India’ assistance app.
  • Launched Project Aastha Cancer-Care Services and Helpdesk at Sawai Man Singh Hospital, Jaipur.
  • Partnered with Father Muller Research to strengthen evidence generation.
  • Partnered with Max Super Speciality Hospitals.
  • Set up global drug development center in India.
2023
  • Entered into agreement to assign lease of MIDC land and sell building.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
GOLDMAN SACHS FUNDS - GOLDMAN SACHS INDIA EQUITY PORTFOLIObulkSell4260664700.0124 Apr 2026
PRUDENTIAL ICICI MUTUAL FUND A/C DISCOVERY FUNDbulkBuy400000470024 Apr 2026

Read More

Pfizer Ltd News

Pfizer Appoints Kishore Bhatia & Associates as Cost Auditors

Pfizer Limited's Board appoints M/s. Kishore Bhatia & Associates (Firm Reg. No. 000294) as Cost Auditors for FY ending March 31, 2027, effective May 12, 2026.

12 May 2026

companies

Pfizer Ltd to Hold 75th AGM on July 28, 2026

Pfizer Limited has announced its 75th Annual General Meeting scheduled for July 28, 2026, to be held via Video-Conferencing/OAVM, as approved by its Board on May 12, 2026.

12 May 2026

companies

Pfizer India Posts FY26 Revenue of ₹2,519.65 Cr

Pfizer Limited reports FY26 revenue from operations of ₹2,519.65 crore, net profit of ₹722.43 crore, and recommends a final dividend of ₹75 per share.

12 May 2026

companies

Pfizer Gets ₹85.74 Cr Tax Demand & Penalty Notice

Pfizer received Income Tax Assessment Order for ₹85.74 crore tax demand and penalty notice for FY2022-23. Company maintains strong defence grounds and expects no material impact.

25 Apr 2026

companies

Pfizer Gets ₹85.74 Cr Tax Demand & Penalty Notice

Pfizer received Income Tax Assessment Order for ₹85.74 crore tax demand and penalty notice for FY2022-23. Company maintains strong defence grounds and expects no material impact.

24 Apr 2026

companies

Read More